RIDGELAND, Miss., Jan. 11, 2005 (PRIMEZONE) -- Knobias announced today that an interview with Dr. Stephen C. Roberts, CEO and Chairman of the Board of GelStat Corporation (OTCBB:GSAC), has just been made available as part of the Knobias Issuer Services program.
In the interview, Knobias' Kirk Thompson was able to ask some key questions about GelStat Corporation, its current direction and its strategies. The interview is available for free at http://cobrand.knobias.com/templates/aware/view/gelstat.htm or directly from Knobias at: http://cobrand.knobias.com/clipreport/clipreport.htm
Also available for free is the Knobias Research report. This report is an all-inclusive and all too rare fact based look at an emerging smallcap company. You may download it here: http://cobrand.knobias.com/templates/aware/view/gelstat.htm
About Issuer Services
Issuer Services includes a national press release service, issuer websites, CEO interviews, non-analytical research reports, Edgar Filing Services, and news based promotional packages. Companies are also featured in the Knobias "Smallcap Clip Report" and receive a full Knobias professional account, which includes the powerful pipe/TRAC product.
About GelStat Corporation
GelStat Corporation is a consumer health care company dedicated to the cost-effective development and marketing of advanced OTC health care products. Development efforts are focused on very large markets where GelStat products can offer improved efficacy, safety, and/or convenience over existing OTCs.
About Knobias
Knobias is a premier financial information provider of real-time news and trading and investing data covering all U.S. equities for investors and security professionals. Knobias (www.knobias.com) was founded in 1999 as the first and largest unbiased information repository for OTC market intelligence. Through its unique, web-based applications, Knobias also provides intraday, real-time surveillance & alerting on all U.S. securities for investors & trading professionals, with special emphasis on all NasdaqNM(TM), NasdaqSC(TM), OTCBB(TM) and Pink Sheet(TM) securities.
Forward-Looking Statements
To the extent that this release discusses any expectations concerning future plans, financial results or performance, such statements are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and are subject to substantial risks and uncertainties. Actual results could differ materially from those anticipated in the forward-looking statements as a result of a number of factors, including but not limited to, the successful closing of the proposed transaction, including the financing, and risks associated with acquisitions generally. Readers are cautioned not to place undue reliance on these forward looking statements, which speak only as of the date hereof and reflect only management's belief and expectations based upon presently available information. These statements, and other forward looking statements, are not guarantees of future performance and involve risks and uncertainties. Knobias receives an all inclusive fee of $1,800 for its Issuer Services package. Knobias assumes no obligation to update any of the forward-looking statements in this release.